Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Bebtelovimab
Emergency use authorization Experimental Antiviral Jun/18/2022
COV2-2130
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022
COV2-2196
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022
Ensitrelvir
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022
REGEN-COV
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Emergency use authorization Experimental Antiviral May/16/2022
ACE2‐Fc
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022
Anakinra 
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Camptothecin
Potential treatment - theoretical effect Natural product Antiviral Jan/31/2022
PF-00835231
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
N(4)-Hydroxycytidine
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
P2C-1F11
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
hu33
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
PDA@Exosome
Potential treatment - pre-clinical evidence Experimental Other treatment Jan/22/2022
Dexamethasone
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
S2K146
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
mAb 222
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022